ORIGINAL RESEARCH article
Front. Oncol.
Sec. Head and Neck Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1593603
The Value Analysis of Tumor Deposit in the Comprehensive Evaluation Before Differentiated Thyroid Cancer RAI Therapy
Provisionally accepted
- The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: This study aimed to investigate the impact of tumor deposit (TD) on Radioiodine (RAI) therapy efficacy in Differentiated Thyroid Cancer (DTC) and explore their potential role in postoperative staging and the American Thyroid Association (ATA) initial risk stratification system before RAI treatment.This study retrospectively analyzed data from a total of 11,278 thyroid cancer surgical patients between 2019 and 2023. Among 2,162 patients were considered eligible for prognostic analysis (2056 cases in the TD-negative group, 106 cases in the TD-positive group). A 1:1 propensity score matching was conducted for the TDpositive group. Single-factor and multiple-factor analyses of prognostic factors were performed for both groups. The predictive abilities of different N stages, TNM staging, and the ATA initial risk stratification system including TD were evaluated.Results: There were 235 cases (2.08%) of TD-positive patients. Multivariate analysis demonstrated that gender, presence of TD, the ATA initial risk stratification system, and TNM staging were independent prognostic factors. In all patients, those in the N1a stage, TNM stage Ⅰ, and ATA intermediate risk group, the cumulative incidence of ER in the TD-positive group was lower than that in the TD-negative group (48.6% vs. 77.8%, 37.5% vs. 78.7%, 35.4% vs. 67.4%; P = 0.019, 0.001, 0.013 respectively). Patients with TD-positive in N1a stage had no significant difference in prognosis compared to TDnegative patients in N1b stage (32.6% vs. 42.6%, P = 0.867); TD-positive patients in TNM stage Ⅰ had similar prognosis to TD-negative patients in TNM stage Ⅱ(37.5% vs.28.9%, P = 0.338); TD-positive patients in the ATA intermediate risk group showed no significant difference in prognosis compared to TD-negative patients in the ATA high risk group (35.4% vs. 12.5%, P = 0.300).TD should be considered as a prognostic factor in the postoperative RAI treatment. We propose incorporating TD into the TNM staging and the ATA initial risk stratification system as a reference, suggesting that TD-positive patients in N1a stage be classified as N1b stage; patients in TNM stage Ⅰ be classified as TNM stage Ⅱ；and the ATA intermediate risk patients be classified as the ATA high risk.
Keywords: tumor deposit, prognosis, Differentiated thyroid cancer, Radioactive iodine, TNM staging, The ATA initial risk stratification system
Received: 14 Mar 2025; Accepted: 05 May 2025.
Copyright: © 2025 Wang, Yang, Li and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Zhiyong Li, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.